Capital Fund Management (CFM)’s Kyntra Bio KYNB Stock Holding History

Capital Fund Management (CFM)’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-411	Closed	-$274K	–	1612
2021 Q2	$274K	Buy	+411	New	+$237K	﹤0.01%	1369
2020 Q4	–	Sell	-448	Closed	-$460K	–	1368
2020 Q3	$460K	Sell	448 -736	-62%	-$792K	0.01%	1063
2020 Q2	$1.2M	Buy	1,184 +857	+262%	+$796K	0.02%	647
2020 Q1	$284K	Buy	+327	New	+$325K	﹤0.01%	1249
2019 Q3	–	Sell	-287	Closed	-$324K	–	1744
2019 Q2	$324K	Buy	+287	New	+$314K	﹤0.01%	1350
2018 Q3	–	Sell	-325	Closed	-$509K	–	2059
2018 Q2	$509K	Buy	+325	New	+$424K	﹤0.01%	1586
2016 Q3	–	Sell	-1,340	Closed	-$550K	–	1638
2016 Q2	$550K	Buy	+1,340	New	+$614K	0.01%	1147

Other funds holding KYNB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Fund Management (CFM)'s KYNB Position: Q3 2021 in Review

Capital Fund Management (CFM) sold out of Kyntra Bio (KYNB) in Q3 2021, closing a stake of 411 shares — an estimated $274K sold.

Capital Fund Management (CFM) first reported a position in KYNB in Q2 2016 and held it in 7 quarters. The position peaked at $1.2M in Q2 2020. 164 funds tracked by Wall St. Rank hold KYNB as of Q3 2021.

Capital Fund Management (CFM) reported no remaining Kyntra Bio position as of Q3 2021 after selling out during the quarter.
Capital Fund Management (CFM) sold 411 Kyntra Bio shares in Q3 2021, an estimated $274K.
Capital Fund Management (CFM) first reported a position in Kyntra Bio in Q2 2016 and held it in 7 quarters.
Capital Fund Management (CFM)'s Kyntra Bio position peaked at $1.2M in Q2 2020.
164 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2021, filed 12 Nov 2021.